Abstract 1108: A novel, selective inhibitor of DNA-dependent protein kinase (DNA-PK) potentiates the effects of DNA-damaging therapies in hepatocellular carcinoma

作者
Catherine E. Willoughby,Huw D. Thomas,Tommy Rennison,Céline Cano,Helen Louise Reeves,Stephen R. Wedge
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:77 (13_Supplement): 1108-1108
标识
DOI:10.1158/1538-7445.am2017-1108
摘要

Abstract DNA-dependent protein kinase (DNA-PK) is a key component in the repair of DNA double-strand breaks via non-homologous end-joining. Studies have found elevated DNA-PK expression and activity in hepatocellular carcinoma (HCC) to be strongly correlated with increased tumor grade, resistance to DNA-damaging therapies and poor survival (1,2). We have explored the selective inhibition of DNA-PK in combination with DNA-damaging agents as a potential therapeutic approach in HCC using NDD0004 - a novel, orally-bioavailable small molecule inhibitor of DNA-PK (in vitro IC50 = 8 nM). NDD0004 was evaluated in a panel of DNA-PK overexpressing human HCC cell lines (Hep3B, HepG2, Huh7) in combination with ionizing radiation or the topoisomerase II poison doxorubicin. DNA-PK activity was determined by Ser2056 phosphorylation status, DNA damage quantified by γH2AX levels, cell proliferation determined by SRB assays and cell survival assessed using clonogenic assays. In vivo efficacy was evaluated using a novel murine model of localized and sustained doxorubicin therapy, involving intra-tumoral injection of doxorubicin-loaded DC M1 polymer beads into established Huh7 human HCC xenografts in CD1 nude mice. Oral twice-daily treatment with 30 mg/kg NDD0004 or vehicle control was commenced 1 hour following bead implantation and continued for up to 20 days (6 mice per group). NDD0004 dose-dependently inhibited activation of DNA-PK in HCC cell lines in vitro in response to ionizing radiation, and significantly increased and sustained DNA damage following treatment. Furthermore, NDD0004 sensitized DNA-PK overexpressing HCC cell lines to doxorubicin and ionizing radiation in proliferation and survival assays by ≥ 5-fold. Combining NDD0004 with doxorubicin-loaded beads in vivo significantly inhibited the rapid growth of HCC tumors when compared to treatment with doxorubicin-loaded bead monotherapy, with the time taken for tumor volumes to quadruple (RTV4) being extended from 11 to 18 days (P<0.01, Mann-Whitney). Individual and combination treatments were well tolerated throughout. Immuno-histochemical analysis revealed γH2AX levels in hepatocytes surrounding doxorubicin-loaded beads to be significantly increased by NDD0004 co-treatment for 72-hours (P<0.02, 2-way ANOVA). In conclusion, selective inhibition of DNA-PK catalytic activity sensitized DNA-PK overexpressing HCC cell lines to doxorubicin chemotherapy and ionizing radiation in vitro, and augmented the anti-tumor activity of localized chemotherapy in HCC xenografts in vivo. These data support the concept of combining a DNA-PK inhibitor with localized DNA-damaging therapies in the treatment of HCC. 1. Cornell et al. (2015) Clin Cancer Res. 21: 925-33 2. Evert et al. (2013) Br J Cancer. 109: 2654-64 Citation Format: Catherine E. Willoughby, Huw D. Thomas, Tommy Rennison, Celine Cano, Helen L. Reeves, Stephen R. Wedge. A novel, selective inhibitor of DNA-dependent protein kinase (DNA-PK) potentiates the effects of DNA-damaging therapies in hepatocellular carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1108. doi:10.1158/1538-7445.AM2017-1108

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhe完成签到,获得积分10
1秒前
orixero的应助被zhang采纳,获得10
2秒前
Nole的应助被醉熏的奇异果采纳,获得10
3秒前
闵乌完成签到,获得积分10
3秒前
李渠完成签到,获得积分10
3秒前
Nole的应助被Summer采纳,获得30
3秒前
wxs完成签到,获得积分10
4秒前
Nole的应助被小fool采纳,获得10
4秒前
4秒前
1812721261发布了新的文献求助10
5秒前
7秒前
TSW发布了新的文献求助10
8秒前
百香果发布了新的文献求助10
8秒前
隐形曼青的应助被三金采纳,获得10
8秒前
9秒前
Wmwmw完成签到,获得积分10
9秒前
www的应助被七月流火采纳,获得10
9秒前
9秒前
wwt完成签到,获得积分20
9秒前
9秒前
10秒前
10秒前
dungaway完成签到,获得积分10
10秒前
11秒前
李健的小迷弟的应助被www采纳,获得10
11秒前
Hello的应助被西北一枝花采纳,获得30
12秒前
Rainbow7完成签到,获得积分10
12秒前
我是老大的应助被桃子汽水采纳,获得10
12秒前
12秒前
13秒前
13秒前
LLJ发布了新的文献求助10
14秒前
zhang发布了新的文献求助10
14秒前
唐雨文发布了新的文献求助10
14秒前
孙梦丹完成签到,获得积分10
14秒前
14秒前
14秒前
黑米粥发布了新的文献求助200
15秒前
不开花花发布了新的文献求助30
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183880
求助须知:如何正确求助?哪些是违规求助? 9573054
关于积分的说明 21828982
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434134
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480634